Forest-derived pharmaceutical value chains
Protecting, cultivating, processing and marketing medicinal materials from forests — from seed and nursery to TCM products — replacing dispersed low-value planting with standardised integrated chains, shown at 20,000-mu bases in Northeast China.
1 · What it gives
Forest-derived pharmaceutical value chains use forest resources for the protection, cultivation, processing, research and marketing of medicinal materials in support of the health industry. They replace small-scale, dispersed, low-value planting with modern, standardised, integrated chains. They operate at commercial scale: examples include a large production base of 20,000 mu and an output of 2 million pills or bottles over three years, with active industrialisation by listed companies.
2 · What it replaces 6
3 · How to implement 4 steps
- 1Seed and nurserySelect seed and breed seedlings in nurseries.
- 2Standard basesEstablish standardised cultivation bases and manage wild resources.
- 3Primary processingProcess at the place of origin.
- 4Deep processingProcess into TCM and related products.
4 · Who delivers
Matched suppliers (matched automatically)
| Abtec | India | Research / RTO | active |
| LG Chem | South Korea | Producer | active |
| EcoFix Kenya Ltd (EFK) | Kenya | Producer | active |
| EGAVET | Egypt | Research / RTO | active |
| SyncoZymes (Shanghai) | China | Producer | active |
| Safi Organics Ltd. | Kenya | Producer | active |
| PT. Central Proteina Prima, Tbk | Indonesia | Producer | active |
| Star Lake/Eppen 星湖科技 (SSE 600866) | China | Producer | active |
| CMPC (BCS: CMPC) | Chile | Producer | active |
| NARO | Uganda | Research / RTO | active |
| Pyrogreen Energy | China | Producer | active |
| Sappi (JSE: SAP) | South Africa | Producer | active |
Leading companies and institutes (from the brief)
Named in the sources: Heilongjiang Lijian Biological, Heilongjiang Zhenbaodao Pharmaceutical, Heilongjiang Kuihua Pharmaceutical and Longjiang Forest Industry. Others are matched by the portal under Forestry and Pharma & biologics.
5 · Rules & route to market
2-3 years (registration trials over seasons)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
The area is governed by national quality standards and sector technical specifications such as the China Forest Medicinal Materials and Product Evaluation Technical Specification, alongside forestry rules.
6 · Money: tenders & grants
| Grant | Enhancing farmer's profitability and resilience through innovations for diversified crops and value chains European Commission · EU | Sep 23, 2027 342 days |
| Grant | Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU | Feb 2, 2027 109 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 341 days |
| Grant | Strengthening evidence-based policies for the resilience of European agriculture and forestry and related … European Commission · EU | Sep 23, 2027 342 days |
| Grant | Developing novel recycling technologies for complex plastic materials applying biotech solutions European Commission · EU | Sep 22, 2027 341 days |
7 · Tech stack & innovations
Main risks from the sources: environmental mismatch, lack of standardised germplasm and seedling quality, difficult forest terrain for mechanisation, and quality control.
Sources 4
- Eco.gov.cn — www.eco.gov.cn 2026-10-16
- Forestry.gov.cn — www.forestry.gov.cn 2026-10-16
- Forestry.gov.cn — www.forestry.gov.cn 2026-10-16
- Hzxy.nefu.edu.cn — hzxy.nefu.edu.cn 2026-10-16